Navigation Links
WHO Gives Its Approval For Bird Flu Test Kit

The go ahead has been given by the World Health Organization (WHO) towards developing a bird flu test kit aimed at pinpointing the H5N1// strain in just a matter of three hours. The developers of the kit are based in Singapore. The kit from Veredus Laboratories, launched in July, was found by the WHO Collaborating Center for Influenza in Australia to be highly specific to the deadly bird flu strain, in addition to being extremely sensitive.

More tests are still needed on the kit, company sources said, to make sure it works on the slightly different strains of the H5N1 virus found in Europe. Chief Executive Rosemary Tan said the Singapore facility, which can produce 100,000 kits a month, has sold them to countries in Asia, the Middle East and Europe.

The kit was used last month in Indonesia to detect human cases, a research scientist said. Veredus' success lies in the test kit's primers, bits of genetic material unique to the H5N1 strain, which anchor onto their identical portions of the gene in virus samples, the company said. These are magnified through a process called polymerase chain reaction (PCR), enabling even minute amounts of the virus to be detected in infected humans and fowl.

Edited IANS
'"/>




Page: 1

Related medicine news :

1. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
2. Gene Therapy Gives Hope For Patients With Muscular Dystrophy
3. Statins Gives New Hope for Increased Survival Rate of Heart Failure Patients
4. US Doctors Association Gives away $110,000 To NGO’
5. Woman In Coma Gives Birth To Daughter
6. Artificial Heart , Gives Hope For Patients Awaiting a Heart Transplant
7. New Eye Surgery Gives Hope To Short-Sighted
8. Jharkhand Gives Health industry status
9. FDA Gives Its Approval For Inhaler
10. Congestion for Use of Clarinex-D 12 Hour cleared – FDA Gives the No
11. FDA Gives Green Signal To Sanofi-Aventis SAs Cancer Drug Taxotere
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: WHO Gives Its Approval For Bird Flu Test Kit

(Date:9/5/2008)...5 /PRNewswire/ -- Arthrosurface, Inc.,( http://www...ve joint,resurfacing systems, announced that it ha... pivotal investigation for its line of focal knee,...re no outstanding safety,concerns" with the device... has been evaluating the safety and efficacy of it...
(Date:9/5/2008)...5 /PRNewswire/ -- On Saturday, September 6, PARI,R...n Network show Today,s,Family as part of their "Br...ding medical device company that provides patients...s and compressors that deliver needed,medications ... the lives of those affected by respiratory,diseas...
(Date:9/5/2008)...t for those overweight or obese at age 45 , ...alf of all American adults will develop osteoarthr...e if they are obese in middle age, a new study say...dition increased as his or her body-mass index (BM...lina at Chapel Hill study. People who were of norm...
(Date:9/5/2008)...k prediction models are enhanced by taking into ac...pair capacity, according to research teams led by ...nderson Cancer Center in two complementary papers ...tion Research . , In the first study to focus on...ts based on increased exposure to certain risks. B...
Breaking Medicine News(10 mins):Health News:Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage 2Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Almost Half of Adults Will Develop Knee Osteoarthritis by 85 2Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3
... in Romania have confirmed the presence of new H5N...ird flu infection in Ostrov // (near the Bulgarian...fected by bird flu. Laboratory examination done o...n confirmed to be positive for bird flu infection....
...hat complex regional pain syndrome is a neurologic...cting small fibers which has the ability to sense ...atic limb pain and other disturbances that continu...ealed. But the causes of the symptoms of the syndr...
...rchers say that they have formulated a combination... It was believed for a long time that new borns di...laid to rest by stringent research. The problem wa...g the basic constitution of infants. Principal i...
... a lesser risk of Parkinson’s, according to novel ...urosurgery and Psychiatry. // The research team, ...06 Parkinson’s patients and 106 healthy people, be...roups’ responded to questions that sought to throw...
Other Medicine News:
(Date:9/6/2008)...acy of First-in-Class Neurally Acting Anti-Migr...aine, LONDON, Sept. 6 /- CoLucid Pha...mpany focusing on therapies for central nervous,sy...lead compound COL-144,in the treatment of acute mi... and effective in relieving migraine headaches. CO...
(Date:9/5/2008)...FirstCall/ -- CEL-SCI Corporation,(Amex: CVM ) an...hritis data,at the Marcus Evans conference on Immu.... Daniel Zimmerman, Senior Vice President of Resea... CEL-SCI,s rheumatoid,arthritis vaccine CEL-2000 p...sed by rheumatoid arthritis in an animal model of ...
(Date:9/4/2008)...Newswire/ -- Cytopia Limited (ASX:,CYT) today anno...e Ib/II,study of CYT997, the company,s novel vascu...an aggressive form of brain cancer known as gliobl...is the first Phase II efficacy study in highly,vas... the second in its,suite of Phase II studies desig...
(Date:9/4/2008)..., and Presented at ESC Congress-, PHILADELPHIA, S...ional,study, the GISSI Heart Failure (GISSI-HF) st...esters reduced all cause mortality and hospital,ad...th chronic heart,failure. These findings are publi... and were presented at the European Cardiovascular...
Breaking Medicine Technology:Phase II Results of COL-144 Presented at European Headache and Migraine Trust International Congress 2008 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 4Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Internal Medicine 2008 media advisory 17936 1Internal Medicine 2008 media advisory 17936 2Immune system kick started in moist nasal lining in sinusitis asthma and colds 17934 1Immune system kick started in moist nasal lining in sinusitis asthma and colds 17934 2Immune system kick started in moist nasal lining in sinusitis asthma and colds 17934 3Scientists aim to boost world energy supplies with microbes 21 3101 1Scientists aim to boost world energy supplies with microbes 21 3101 2Scientists aim to boost world energy supplies with microbes 21 3101 3Scientists aim to boost world energy supplies with microbes 21 3101 4Scientists determine drug target for the most potent botulinum neurotoxin 3099 1Scientists determine drug target for the most potent botulinum neurotoxin 3099 2
... Evaluable Patients Receiving Combination of,Bavit...,Tumor Response or Stable Disease - , - 75% of ... Gemcitabine , ,Achieved Objective Tumor...Patients Receiving Combination of Bavituximab Plus...ive Tumor Response - , - Trial Results Suppo...
... (Asasantin® Retard) considered by many as,fir...IM, Germany, 31 May 2007 - New data presented toda...w confirm that therapy,with dipyridamole plus ASA ...d as Aggrenox® or Asasantin® Retard) is su...ents in patients who had,a TIA or minor ischaemic ...
Other Medicine Technology:Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 2Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 3Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 4Peregrine Pharmaceuticals Reports Positive Top-Line Results in,Bavituximab Combination Therapy Trial in Advanced Cancer Patients 5New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 2New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 3New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 4
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
...RUP Laboratories is a national reference laborator...research and development. ARUP offers an extensive...sts in clinical and anatomic pathology. Owned by t...include more than half of the nation's university ...
Medicine Products: